Clinical Trial Update: Study Comparing Tapinarof Cream 1% To VTAMA ® (Tapinarof Cream 1%) In the Treatment of Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 study evaluating Tapinarof Cream 1% versus VTAMA for plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Tapinarof Cream 1% (tapinarof)

Snippet

Sponsor: Teva Pharmaceuticals USA | Conditions: Plaque Type Psorisis | Phase 3 | Status: COMPLETED